Abhinav Goyal, MD, MHS, FACC, FAHA is an academic cardiologist and clinical investigator who is a Professor of Medicine (Division of Cardiology) at the Emory School of Medicine, with a joint appointment in the Department of Epidemiology at Emory Rollins School of Public Health. Dr. Goyal also serves as the Chief Quality Officer for the Emory Heart and Vascular Center. He is responsible for directing all quality-related initiatives in the Emory Heart and Vascular Center, including providing physician oversight for Emory Hospitals' participation in the American College of Cardiology National Cardiovascular Data Registry (CathPCI Registry and LAAO Registry); American Heart Association (AHA) GWTD-CAD Registry and Mission: Lifeline program for patients with acute heart attacks; AHA COVID-19 Registry; and The Emory Clinic's quality improvement initiatives pertaining to cardiovascular performance measures. Dr. Goyal’s research interests include population research investigating the link between diabetes or dysglycemia and cardiovascular disease; quality, health services research, and outcomes research in cardiovascular medicine; classification and management of acute myocardial infarction; and cardiovascular clinical trials.
To learn more about Dr. Goyal's clinical, research, service, and teaching contributions, please click on the "Curriculum Vitae" link below, or visit the link
Contact Information
1462 Clifton Rd NE , Room 531
Atlanta , GA 30322
Room 531
Phone: 404-727-8758
Fax: 404-727-6495
Email: AGOYAL4@EMORY.EDU
Areas of Interest
- Cardiovascular Diseases
- Health Outcomes
- Health Services Research
Education
- MD 1999, Northwestern University Medical School
- MHS (Masters in Health Sciences) 2006, Duke University
- Internal Medicine Residency 2002, University of Pennsylvania Medical Center
- Cardiology Fellowship (Clinical) 2004, Duke University Medical Center
- Nuclear Cardiology Fellowship (Clinical) 2007, Duke University Medical Center
- Cardiovascular Research Fellowship 2006, Duke Cliincal Research Institute
- Cardiovascular Research Fellowship 2007, Population Health Res. Inst., McMaster Univ
Publications
- Goyal A, Bornstein WA, 2013, Health system-wide quality programs to improve blood pressure control, JAMA, 310, 695-6
- Goyal A, Spertus JA, Gosch K, Venkitachalam L, Jones PG, van den Berghe G, Kosiborod M, 2012, Serum potassium levels and mortality in acute myocardial infarction, JAMA, 307, 157-64
- Nerenberg KA, Goyal A, Xavier D, Sigamani A, Ng J, Mehta SR, Díaz R, Kosiborod M, Yusuf S, Gerstein HC, 2011, Piloting a novel algorithm for glucose control in the CCU: the RECREATE (REsearching Coronary REduction by Appropriately Targeting Euglycemia) Trial., Diabetes Care, , doi: 10.2337/dc11-0706
- Goyal A, Bhatt DL, Steg PG, Gersh BL, Alberts MJ, Ohman EM, Corbalán R, Eagle KA, Gaxiola E, Gao R, Goto S, D’Agostino RB, Califf RM, Smith SC, Wilson PW., 2010, Attained educational level and incident atherothrombotic events in low-and-middle income compared with high-income countries., Circulation, 122, 1167-75
- Goyal A, Norton CR, Thomas TN, Davis RL, Butler J, Ashok V, Zhao L, Vaccarino V, Wilson PW, 2010, Predictors of incident heart failure in a large insured population: a one million person-year follow-up study, Circulation: Heart Failure, 3, 698-705
- Goyal A, Mehta SR, Diaz R, Gerstein HC, Afzal R, Xavier D, Lisheng L, Pais P, Yusuf S., 2009, Differential clinical outcomes associated with hypoglycemia and hyperglycemia in acute myocardial infarction. , Circulation, 120, 2429-2437
- Kosiborod M, Inzucchi SE, Krumholz HM, Masoudi FA, Goyal A, Xiao L, Jones PG, Fiske S, Spertus JA. , 2009, Glucose normalization and outcomes in patients hospitalized with acute myocardial infarction – defining the optimal glucose target range., Arch Intern Med, 169, 438-446
- Kosiborod M, Inzucchi SE, Goyal A, Krumholz HM, Masoudi FA, Xiao L, Spertus JA. , 2009, The relationship between spontaneous and iatrogenic hyperglycemia and mortality in patients hospitalized with acute myocardial infarction., JAMA, 301, 1556-1564
- Goyal A, Nerenberg K, Gerstein HC, Umpierrez G, Wilson PWF. , 2008, Insulin therapy in acute coronary syndrome: a current appraisal of completed and ongoing randomized trials with important clinical endpoints., Diabetes Vasc Dis Res, 5, 276-84
- Díaz R (shared first author), Goyal A (shared first author), Mehta S, Afzal R, Xavier D, Pais P, Chrolavicius S, Zhu J, Kazmi K, Liu L, Budaj A, Zubaid M, Avezum A, Ruda M, Yusuf S., 2007, Glucose-insulin-potassium (GIK) therapy in patients with ST-segment elevation myocardial infarction., JAMA, 298, 2399-2405
- Goyal A, Alexander JH, Hafley GE, Graham SH, Mehta RH, Mack MJ, Wolf RK, Cohn LH, Kouchoukos NT, Harrington RA, Gennevois D, Gibson CM, Califf RM, Ferguson Jr., TB, Peterson ED., 2007, Outcomes associated with the use of secondary prevention medications following coronary artery bypass graft surgery., Ann Thorac Surg, 83, 993-1001
- Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW, Granger CB. , 2006, Prognostic significance of the change in glucose in first 24 hours after acute myocardial infarction: results from the CARDINAL study., Eur Heart J, 27, 1289-97
- Goyal A, Yusuf S., 2006, The burden of cardiovascular disease in the Indian subcontinent. , Indian J Med Res , 124, 235-44
- Alexander JH, Hafley G, Harrington RA, Peterson ED, Ferguson TB Jr., Lorenz TJ, Goyal A, Gibson M, Mack MJ, Gennevois D, Califf RM, and Kouchoukos NT, for the PREVENT IV Investigators., 2005, Efficacy and safety of edifoligide, an E2F transcription factor decoy, for the prevention of vein graft failure following coronary artery bypass graft surgery., JAMA, 294, 2446-54
- , 1945, To view complete list of publications, please click on "View Resume" link above., , ,